Accès libre

Synergistic Antiproliferative Effects of Chondroitin Sulfate and Fucoidan in Tumor-derived Spheroids: Insights From a 3D Cell Culture Approach

E Nováková

E Nováková

  • Comenius University Bratislava, Faculty of Natural Sciences, Department of Microbiology and VirologyBratislava, Slovak Republic
  • Comenius University Bratislava, Faculty of Pharmacy, Department of Galenic PharmacyBratislava, Slovak Republic
  • Biomedical Research Center of the Slovak Academy of Sciences, Institute of VirologyBratislava, Slovak Republic
Recherchez cet auteur sur
Sciendo|Google Scholar
Nováková, E
, 
J Zima

J Zima

Comenius University Bratislava, Faculty of Pharmacy, Department of Galenic PharmacyBratislava, Slovak Republic
Recherchez cet auteur sur
Sciendo|Google Scholar
Zima, J
, 
M Špaglová

M Špaglová

Comenius University Bratislava, Faculty of Pharmacy, Department of Galenic PharmacyBratislava, Slovak Republic
Recherchez cet auteur sur
Sciendo|Google Scholar
Špaglová, M
, 
M Labudová

M Labudová

  • Comenius University Bratislava, Faculty of Natural Sciences, Department of Microbiology and VirologyBratislava, Slovak Republic
  • Biomedical Research Center of the Slovak Academy of Sciences, Institute of VirologyBratislava, Slovak Republic
Recherchez cet auteur sur
Sciendo|Google Scholar
Labudová, M
 et 
M Šupolíková

M Šupolíková

  • Comenius University Bratislava, Faculty of Natural Sciences, Department of Microbiology and VirologyBratislava, Slovak Republic
  • Comenius University Bratislava, Faculty of Pharmacy, Department of Galenic PharmacyBratislava, Slovak Republic
Recherchez cet auteur sur
Sciendo|Google Scholar
Šupolíková, M
  
20 janv. 2025
Synergistic Antiproliferative Effects of Chondroitin Sulfate and Fucoidan in Tumor-derived Spheroids: Insights From a 3D Cell Culture Approach's Cover Image
À propos de cet article
Article précédent
Article suivant
Citez
Télécharger la couverture
Catégorie d'article: Research paper
Publié en ligne: 20 janv. 2025
Pages: 25 - 33
Reçu: 04 déc. 2024
Accepté: 12 déc. 2024
DOI: https://doi.org/10.2478/afpuc-2024-0015
Mots clés
© 2024 E Nováková et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Figure 1.

Comparison of non-tumor NIH3T3 cell line in 2D and 3D cell culture: A) non-tumor NIH3T3 cell line in 2D cell culture forming a cell monolayer (100× magnification); B) non-tumor NIH3T3 cell line in 3D cell culture forming a spheroid (100× magnification).
Comparison of non-tumor NIH3T3 cell line in 2D and 3D cell culture: A) non-tumor NIH3T3 cell line in 2D cell culture forming a cell monolayer (100× magnification); B) non-tumor NIH3T3 cell line in 3D cell culture forming a spheroid (100× magnification).

Figure 2.

Comparison of the Hepa1c1c7 tumor cell line in 2D and 3D cell culture: A) Hepa1c1c7 tumor cell line in 2D cell culture forming a cell monolayer (100× magnification); B) Hepa1c1c7 tumor cell line in 3D cell culture forming a spheroid (100× magnification).
Comparison of the Hepa1c1c7 tumor cell line in 2D and 3D cell culture: A) Hepa1c1c7 tumor cell line in 2D cell culture forming a cell monolayer (100× magnification); B) Hepa1c1c7 tumor cell line in 3D cell culture forming a spheroid (100× magnification).

Figure 3.

Spheroids from the non-tumor cell line NIH3T3 after treatment with A) chondroitin sulfate (CS), B) fucoidan (F), C) a combination of chondroitin sulfate and fucoidan (CS + F). Day 3 – first addition of substances; Day 7 – last addition of substances. Spheroids were photographed at 50× magnification. Up arrow (↑) – spheroids that increased their area compared to control spheroids; down arrow (↓) – spheroids that decreased their area compared to control spheroids; equal to (=) – spheroids that have approximately the same area compared to control spheroids.
Spheroids from the non-tumor cell line NIH3T3 after treatment with A) chondroitin sulfate (CS), B) fucoidan (F), C) a combination of chondroitin sulfate and fucoidan (CS + F). Day 3 – first addition of substances; Day 7 – last addition of substances. Spheroids were photographed at 50× magnification. Up arrow (↑) – spheroids that increased their area compared to control spheroids; down arrow (↓) – spheroids that decreased their area compared to control spheroids; equal to (=) – spheroids that have approximately the same area compared to control spheroids.

Figure 4.

Spheroids from the Hepa1c1c7 tumor cell line after treatment with A) chondroitin sulfate (CS), B) fucoidan (F), and C) a combination of chondroitin sulfate and fucoidan (CS + F). Day 3 – first addition of substances; Day 7 – last addition of substances. Spheroids were photographed at 50× magnification. Up arrow (↑) – spheroids that increased their area compared to control spheroids; down arrow (↓) – spheroids that decreased their area compared to control spheroids; equal to (=) – spheroids that have approximately the same area compared to control spheroids.
Spheroids from the Hepa1c1c7 tumor cell line after treatment with A) chondroitin sulfate (CS), B) fucoidan (F), and C) a combination of chondroitin sulfate and fucoidan (CS + F). Day 3 – first addition of substances; Day 7 – last addition of substances. Spheroids were photographed at 50× magnification. Up arrow (↑) – spheroids that increased their area compared to control spheroids; down arrow (↓) – spheroids that decreased their area compared to control spheroids; equal to (=) – spheroids that have approximately the same area compared to control spheroids.

Figure 5.

Flow cytometric analysis of non-tumor NIH3T3 cell lines treated with A) chondroitin sulfate (CS), B) fucoidan (F), and C) a combination of chondroitin sulfate and fucoidan (CS + F), and D) phosphate-buffered saline (PBS). Dead cells are shown on the top left, necrotic cells on the top right, live cells on the bottom left, and apoptotic cells are shown on the bottom right.
Flow cytometric analysis of non-tumor NIH3T3 cell lines treated with A) chondroitin sulfate (CS), B) fucoidan (F), and C) a combination of chondroitin sulfate and fucoidan (CS + F), and D) phosphate-buffered saline (PBS). Dead cells are shown on the top left, necrotic cells on the top right, live cells on the bottom left, and apoptotic cells are shown on the bottom right.

Figure 6.

Flow cytometric analysis of Hepa1c1c7 tumor cell line treated with A) chondroitin sulfate (CS), B) fucoidan (F), and C) a combination of chondroitin sulfate and fucoidan (CS + F), and D) phosphate-buffered saline (PBS). Dead cells are shown on the top left, necrotic cells on the top right, live cells on the bottom left, and apoptotic cells are shown on the bottom right.
Flow cytometric analysis of Hepa1c1c7 tumor cell line treated with A) chondroitin sulfate (CS), B) fucoidan (F), and C) a combination of chondroitin sulfate and fucoidan (CS + F), and D) phosphate-buffered saline (PBS). Dead cells are shown on the top left, necrotic cells on the top right, live cells on the bottom left, and apoptotic cells are shown on the bottom right.

The concentration of F and CS_

Dilution in DMEM CS (mmol/L) F (mmol/L) CS + F (mmol/L)
1:1 0.0620 0.0920 0.0620 0.0920
1:2 0.0310 0.0460 0.0310 0.0460
1:4 0.0155 0.0230 0.0155 0.0230

Quantitative representation of cells in spheroids prepared from the NIH3T3 cell line compared to Hepa1c1c7 cell line evaluated by flow cytometry (5000 cells)_

NIH3T3 cell line
Living cells (%) Apoptotic cells (%) Dead cells (%) Necrotic cells (%)
CS 66.43 ± 4.43 20.98 ± 1.03 9.79 ± 0.52 2.80 ± 0.18
F 13.53 ± 3.60 38.72 ± 4.09 1.50 ± 0.17 46.25 ± 2.97
CS + F 28.30 ± 1.65 19.10 ± 1.05 24.23 ± 5.28 28.37 ± 1.78
PBS 31.57 ± 3.81 32.67 ± 10.05 4.61 ± 0.50 31.15 ± 6.46
Hepa1c1c7 cell line
Living cells (%) Apoptotic cells (%) Dead cells (%) Necrotic cells (%)
CS 29.18 ± 3.69 29.57 ± 18.29 3.89 ± 0.55 37.36 ± 5.97
F 49.65 ± 4.77 27.66 ± 6.83 9.93 ± 0.25 12.75 ± 1.25
CS + F 41.52 ± 3.76 31.50 ± 6.55 19.84 ± 5.80 7.14 ± 0.83
PBS 50.00 ± 8.15 33.22 ± 2.52 7.09 ± 0.67 9.69 ± 0.45
Langue:
Anglais
Périodicité:
2 fois par an
Sujets de la revue:
Pharmacie, Pharmacie, autres
RSS Feed de la revue